Senator Worried About FDA Going ‘Rogue’

A senator from a state hit by soaring painkiller abuse is worried that the next leader of the Food and Drug Administration could “go rogue” and approve unnecessary opioids and further contribute to a growing epidemic.

The White House has nominated well-respected clinical researcher Robert Califf to be the next FDA commissioner. While Califf can expect questions on food safety and the speed of drug approvals during his confirmation process in the Senate, one senator wants to hear his thoughts on opioids.

Sen. Joe Manchin, D-W.Va., said Tuesday that he wants a commitment that the agency will be held responsible on opioid approvals after several controversial decisions.

The agency “cannot go rogue as they have been going, bringing things to the market because they think they know best,” Manchin told the Washington Examiner after speaking at a symposium on prescription drug abuse sponsored by the Hazelden Betty Ford Foundation.